Becton, Dickinson and Company's Q1 2025 Earnings: What to Expect

Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. With a market cap of $68.5 billion, the company operates through BD Medical, BD Life Sciences, and BD Interventional segments.

The healthcare giant is expected to announce its first-quarter earnings on Thursday, Feb. 6. Ahead of the event analysts expect BDX to report a non-GAAP profit of $2.98 per share, up 11.2% from $2.68 per share reported in the year-ago quarter. Furthermore, the company has surpassed Wall Street’s bottom-line estimates in each of the past four quarters. Its adjusted EPS for the last reported quarter surged 11.4% year-over-year to $3.81, exceeding analysts' estimates by 1.1%.